Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Personalized Feedback Alone on Substance Use Behaviors

This study has been completed.
University of Missouri, St. Louis
Institute of Mental Health
Information provided by (Responsible Party):
University of Missouri-Columbia Identifier:
First received: December 23, 2011
Last updated: August 16, 2016
Last verified: January 2013

Screening and brief intervention (SBIRT) generally involves universal screening for risky substance use behaviors in medical settings and the immediate provision of a 3-15 minute intervention to those found to be at risk. In this pilot study, we seek to develop a more efficient and effective approach to providing brief behavioral health interventions in the field by comparing a brief coach directed intervention to a tailored report only group. The goal is to create a cost-effective and sustainable system that provides consumers with tailored information that will help them both initiate and sustain the lifestyle changes necessary for improving their overall health.

Hypothesis 1: In a medical setting, personalized feedback alone will be associated with a reduction in risky substance use behaviors.

Hypothesis 2: In a medical setting, personalized feedback alone will have the same impact on behavior as that information plus a brief coach education session on risky substance use behaviors.

Condition Intervention
Risky Alcohol and Other Substance Use Patterns
Behavioral: Personalized feedback report
Behavioral: Personalized feedback report plus education

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Brief Education to Reduce Health Care Consumers' Risky Substance Use Behaviors: How Brief is Brief?

Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • Substance use behaviors and consequences [ Time Frame: 1 month follow-up ] [ Designated as safety issue: No ]
    Interview questionnaire includes items concerning substance use behaviors (e.g., the number of drinks in the last 7 days) and consequences {e.g., ''During the past month, how often have you failed to do what was normally expected of you because of your use of alcohol?'

Secondary Outcome Measures:
  • Substance use behavioral intentions [ Time Frame: 1 month follow-up ] [ Designated as safety issue: No ]
    Interview questionnaire that asks participants about their memory of the materials provided in the intervention, their motivation toward change, and their self-reported change efforts.

Enrollment: 40
Study Start Date: February 2012
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Personalized feedback plus education
Treatment as usual with participants receiving a personalized feedback report about the risks associated with their current substance use behaviors and a brief (5-15 minute) motivational interviewing based education session provided by a trained health coach.
Behavioral: Personalized feedback report plus education
Persons receive both a brief education session and the personalized feedback report. This is the currently implemented service approach.
Experimental: Personalized feedback report alone
Provision of the personalized feedback report alone.
Behavioral: Personalized feedback report
Participants receive the personalized feedback report but no additional education.


Ages Eligible for Study:   18 Years to 105 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Low level risky substance use

Exclusion Criteria:

  • high substance use risk levels
  • potential alcohol or drug addiction or dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01501318

United States, Missouri
University of Missouri Hospital ER
Columbia, Missouri, United States, 65212
Sponsors and Collaborators
University of Missouri-Columbia
University of Missouri, St. Louis
Institute of Mental Health
Principal Investigator: Matthew G Hile, PhD Missouri Institute of Mental Health
  More Information

Responsible Party: University of Missouri-Columbia Identifier: NCT01501318     History of Changes
Other Study ID Numbers: 1200450 
Study First Received: December 23, 2011
Last Updated: August 16, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by University of Missouri-Columbia:
brief intervention
drug abuse processed this record on September 28, 2016